These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22017508)

  • 1. Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order.
    Yamazoe Y; Ito K; Yoshinari K
    Drug Metab Rev; 2011 Nov; 43(4):409-39. PubMed ID: 22017508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations.
    Park JY; Harris D
    J Med Chem; 2003 Apr; 46(9):1645-60. PubMed ID: 12699383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unimolecular and bimolecular binding system for the prediction of CYP2D6-mediated metabolism.
    Sato K; Yamazoe Y
    Drug Metab Dispos; 2012 Mar; 40(3):486-96. PubMed ID: 22159753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting oxidation sites with order of occurrence among multiple sites for CYP4A-mediated reactions.
    Yamaura Y; Yoshinari K; Yamazoe Y
    Drug Metab Pharmacokinet; 2011; 26(4):351-63. PubMed ID: 21422671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1.
    Lewis DF; Sams C; Loizou GD
    J Biochem Mol Toxicol; 2003; 17(1):47-52. PubMed ID: 12616646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform.
    Lewis DF; Bird MG; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 2000 Jan; 30(1):1-25. PubMed ID: 10659948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of regioselectivity and preferred order of metabolisms on CYP1A2-mediated reactions. Part 1. Focusing on polycyclic arenes and the related chemicals.
    Yamazoe Y; Ito K; Yamamura Y; Iwama R; Yoshinari K
    Drug Metab Pharmacokinet; 2016 Oct; 31(5):363-384. PubMed ID: 27665699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of two-dimensional template system for the prediction of CYP2B6-mediated reaction sites.
    Koyama N; Yamazoe Y
    Drug Metab Pharmacokinet; 2011; 26(4):309-30. PubMed ID: 21403419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates.
    Hartman JH; Martin HC; Caro AA; Pearce AR; Miller GP
    Toxicology; 2015 Dec; 338():47-58. PubMed ID: 26463279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refined CYP2E1
    Yamazoe Y; Murayama N; Yoshinari K
    Drug Metab Pharmacokinet; 2021 Dec; 41():100413. PubMed ID: 34673327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity.
    Lewis DF; Bird MG; Parke DV
    Toxicology; 1997 Mar; 118(2-3):93-113. PubMed ID: 9129165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. π-π Stacking mediated drug-drug interactions in human CYP2E1.
    Liu Y; Liu BY; Hao P; Li X; Li YX; Wang JF
    Proteins; 2013 Jun; 81(6):945-54. PubMed ID: 23349037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A negative cooperativity mechanism of human CYP2E1 inferred from molecular dynamics simulations and free energy calculations.
    Li J; Wei DQ; Wang JF; Li YX
    J Chem Inf Model; 2011 Dec; 51(12):3217-25. PubMed ID: 22077825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mechanism for ethanol oxidation mediated by cytochrome P450 2E1: bulk polarity of the active site makes a difference.
    Wang Y; Yang C; Wang H; Han K; Shaik S
    Chembiochem; 2007 Feb; 8(3):277-81. PubMed ID: 17219453
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of cytochrome P-450 2E1 in methacrylonitrile metabolism and disposition.
    Ghanayem BI; Sanders JM; Chanas B; Burka LT; Gonzalez FJ
    J Pharmacol Exp Ther; 1999 May; 289(2):1054-9. PubMed ID: 10215687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a ubiquitination-Target/Substrate-interaction domain of cytochrome P-450 (CYP) 2E1.
    Banerjee A; Kocarek TA; Novak RF
    Drug Metab Dispos; 2000 Feb; 28(2):118-24. PubMed ID: 10640507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A repressive cross-regulation between catalytic and promoter activities of the CYP1A1 and CYP2E1 genes: role of H(2)O(2).
    Morel Y; de Waziers I; Barouki R
    Mol Pharmacol; 2000 Jun; 57(6):1158-64. PubMed ID: 10825386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
    Zhukov A; Ingelman-Sundberg M
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
    Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
    J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.